Does TADALAFIL Cause Benign prostatic hyperplasia? 596 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 596 reports of Benign prostatic hyperplasia have been filed in association with TADALAFIL (Esokalli Testosterone Booster Oral Dissolving Film). This represents 1.9% of all adverse event reports for TADALAFIL.
596
Reports of Benign prostatic hyperplasia with TADALAFIL
1.9%
of all TADALAFIL reports
1
Deaths
44
Hospitalizations
How Dangerous Is Benign prostatic hyperplasia From TADALAFIL?
Of the 596 reports, 1 (0.2%) resulted in death, 44 (7.4%) required hospitalization, and 7 (1.2%) were considered life-threatening.
Is Benign prostatic hyperplasia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TADALAFIL. However, 596 reports have been filed with the FAERS database.
What Other Side Effects Does TADALAFIL Cause?
Headache (3,196)
Drug ineffective (2,943)
Dyspnoea (2,881)
Death (1,917)
Diarrhoea (1,667)
Dizziness (1,374)
Nausea (1,368)
Asthenia (1,230)
Fatigue (1,135)
Hypertension (1,044)
What Other Drugs Cause Benign prostatic hyperplasia?
TAMSULOSIN (304)
FINASTERIDE (266)
PANTOPRAZOLE (261)
PREDNISONE (257)
ALBUTEROL (254)
ASPIRIN (243)
TIOTROPIUM (235)
RAMIPRIL (193)
AMLODIPINE (179)
PREGABALIN (159)
Which TADALAFIL Alternatives Have Lower Benign prostatic hyperplasia Risk?
TADALAFIL vs TAFAMIDIS
TADALAFIL vs TAFAMIDIS MEGLUMINE
TADALAFIL vs TAFASITAMAB
TADALAFIL vs TAFASITAMAB-CXIX
TADALAFIL vs TAFINLAR